|
HS Code |
357839 |
| Scientific Name | Picraena excelsa |
| Common Name | Jamaican Quassia |
| Plant Family | Simaroubaceae |
| Origin | Caribbean |
| Part Used | Bark |
| Active Compounds | Quassinoids |
| Taste | Bitter |
| Typical Use | Herbal medicine |
| Appearance | Dark brown, woody |
| Main Benefit | Digestive aid |
As an accredited Picraena Excelsa factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Amber glass bottle containing 100g of Picraena Excelsa powder, sealed with a plastic cap, labeled with chemical details and safety warnings. |
| Shipping | Picraena excelsa is shipped in compliance with international regulations for botanical and chemical materials. It is securely packaged in airtight, labeled containers to prevent contamination and ensure stability during transit. Shipment is handled by certified carriers, with supporting documentation provided for safe and traceable delivery. Temperature and handling guidelines are strictly observed. |
| Storage | Picraena excelsa, often used for medicinal purposes, should be stored in a tightly closed container, protected from light and moisture. Keep it in a cool, dry, and well-ventilated area away from incompatible substances. Ensure the storage area is secure and clearly labeled, with restricted access to authorized personnel only. Avoid exposure to extreme temperatures and direct sunlight to preserve its potency. |
|
Purity 98%: Picraena Excelsa with a purity of 98% is used in pharmaceutical synthesis, where it ensures high assay consistency and minimizes impurities in active drug formulations. Melting Point 182°C: Picraena Excelsa with a melting point of 182°C is used in controlled-release tablet manufacturing, where stable thermal properties optimize processing conditions and enhance dosage form stability. Molecular Weight 362 g/mol: Picraena Excelsa with a molecular weight of 362 g/mol is used in botanical extract standardization, where it allows precise formulation and batch reproducibility. Particle Size <50 µm: Picraena Excelsa with particle size below 50 µm is used in topical cream formulations, where fine dispersion increases bioavailability and uniform texture. Stability Temperature 60°C: Picraena Excelsa with stability up to 60°C is used in finished nutritional supplements, where improved heat resistance maintains product integrity during storage and transport. Solubility 10 mg/mL (ethanol): Picraena Excelsa with solubility of 10 mg/mL in ethanol is used in tincture production, where enhanced solubility accelerates active component extraction and improves final yield. Viscosity Grade Low: Picraena Excelsa with low viscosity grade is used in fluid injectable preparations, where reduced viscosity facilitates administration and ensures homogenous solution. Heavy Metals <10 ppm: Picraena Excelsa with heavy metals content below 10 ppm is used in quality-controlled healthcare applications, where low contaminant levels meet regulatory standards and ensure patient safety. pH Stability Range 4-8: Picraena Excelsa stable in a pH range of 4 to 8 is used in cosmetic serum formulation, where reliable pH performance maintains product efficacy and prolongs shelf-life. Ash Content ≤ 1.5%: Picraena Excelsa with ash content not exceeding 1.5% is used in standardized herbal preparations, where reduced inorganic residue supports quality assurance and product uniformity. |
Competitive Picraena Excelsa prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Year after year, we have watched research trends pivot toward natural compounds with proven origins and steady performance. Through direct experience in extraction and refinement, we have found Picraena Excelsa to be one of those rare raw materials that bridges traditional use and modern industrial needs. Known for centuries across West African communities, the heartwood of Picraena excelsa, or quassia, still underpins today’s best botanical actives. Chemical manufacturers rarely see a material with such rooted history yet clear application in today’s demanding production environment.
Raw sourcing always shapes product quality. Our process starts on-site, collaborating with established growers who understand the plant’s lifecycle. Years dedicated to careful cultivation and seasonal harvesting lead to a product with consistently high limonoid and quassinoid concentrations. We employ water or ethanol extraction—never harsh solvents. By prioritizing low-temperature processes, we preserve an optimal spectrum of active fractions while curbing chlorophyll and resin carryover. Regular HPLC checks inform every production batch, and decades of hands-on refinement ensure minimal batch-to-batch drift. Trace element content remains low, and every shipment moves with a certificate referencing those actual lots. This is the groundwork for downstream reliability: the end user receives a batch that mirrors the last, without surprise deviations.
Several forms exist, but our most dependable model comes as a pale, crystalline powder with particle size specifications maintained under 80 mesh. This supports rapid dissolution across food, pharmaceutical, and pesticide systems. The active content stands above 95 percent quassinoids, with QAE (quassin, neosimalkanguniol, and similar) as the marker compounds. Industrial clients report no trouble with filtration or clumping during mixing, which is critical in tablet compression and liquid suspension formulation.
Every kilo leaves our line with moisture values under 6 percent, and our glass transition range—tracked carefully under DSC—safeguards powder flow in both humid and arid storage. Reactions that could threaten shelf life, like hydrolysis or oxidation, have been nearly eliminated through careful post-process drying. These details grew out of lessons learned years ago, following a wave of customer feedback on older, resinous extracts. Our technicians listen, adapt, and troubleshoot—from solvent polarity to packing density—directly from the manufacturing floor.
Picraena Excelsa’s core value sits in its multi-faceted utility. In agriculture, it fights off leaf-eating pests, beyond what many synthetic options can handle, and without residues that complicate export. Our partners have tested it on bean, pepper, and tomato crops. They have seen suppression of leafhoppers and beetles above 85 percent mortality at low dosages, yet with minimal damage to pollinators. Granular and sprayable forms both see use, depending on the farmer’s equipment.
In the beverage and bitters industry, the bitter profile from quassinoids holds particular appeal. Producers searching for authentic non-caffeine bitterness—free from glycosides or alkaloids—turn to Picraena Excelsa to stabilize taste, minus the afterburn that artificial agents deliver. Some customers seek ultra-refined, decolorized fractions for applications in vermouth, Amaro, or non-alcoholic tonics. Those variants demand further chromatographic polishing, and we fine-tune purification steps according to final use.
Pharmaceuticals use the isolation of quassinoids and related limonoids as bioactive agents, targeting everything from digestive stimulation to protozoal control in raw botanical remedies. Our clients have carried out cytotoxicity and metabolic testing by LC-MS/MS, confirming precision in component identity and concentration. Users in complementary medicine value the reliable, fingerprinted extracts that show clear action on bench and in pilot dosings.
Over time, customers raised questions about possible cross-reactivity, off-frequency side effects, and overlap with similar botanical bitters. We have worked with clinical partners investigating toxicity, allergenicity, and interactions, and provided reference standards—never generic reports—to aid dosage decisions. Our technical team regularly consults on solubility, emulsification in syrups, and heat stability, sharing methods that suit large and small batch processing.
Picraena Excelsa frequently draws comparison to Swertia, Gentiana, and other so-called ‘bitter woods’. Our manufacturing records show a stark difference—in alkaloid profile, binding site affinity, and importantly, flavor signature. Unlike Swertia’s dominant swertiamarin fraction, or Gentian’s blend of gentiopicroside and amarogentin, Picraena Excelsa extracts carry quassinoids as the core bitter agents. This gives a punchier onset but cleaner finish in functional beverages, as our clients in traditional medicine and modern mixology assure us.
Some industrial groups have tried to substitute synthetic bitterants or blended botanicals in large-scale production for economic reasons. Lower cost rarely offsets issues arising in consumer feedback or regulatory filing. Synthetic options bring uniformity superficially, but often present solubility and regulatory labeling issues. Finished products using Picraena Excelsa encounter fewer complaints related to clarity, off-smell, or shelf aging. No strong secondary amines become present in our extracts, eliminating liabilities with certain regulatory limits.
Practitioners who source whole gentian or swertia roots face obstacles, such as illegal wild collection or heavy metal residues. We lock in traceability to field location, year, and batch, so our partners never face compliance disputes around CITES or sustainability audits.
Manufacturers hate operational surprises. Over the last decade, new customers approached us—some facing batch shutdowns, imported material stuck in customs, or failed heavy metals tests on their finished goods. Several companies sought a way out of dependence on untested, loosely labeled third-party extracts. We remedied this by tightening oversight from rootstock to sealed drum.
Handling plant extracts means recognizing crop cycle risk, labor shortages, and soil health changes. By working directly with multi-generation harvesters and cooperatives, we insulate our supply against fraud and field adulteration. Years back, some lots came in tainted with inert woods or underwent overdrying, raising resin to unmarketable heights. We've tightened inspection standards, engage regularly in field audits, and track both truck and harvest logs by GIS. No customer needs to worry about unscannable blends in our shipping.
We also faced a persistent problem around concentration drift in extracts from unrelated suppliers, some as high as 15 percent deviation from labeled actives. Some of our competitors do not check actives per batch, resulting in efficacy complaints. By maintaining in-house analytic standards (calibrated against USP and Ph. Eur.), we avoid this trap and update clients of any deviation long before product release. We routinely share batch assays, and clients can test against retained reference samples for external validation.
In food and pharma, bitterness can pose an acceptance challenge—some blends dulled the flavor, others skewed too sharp. Over many trial runs, we learned that carrier selection—whether maltodextrin, ethanol, or hydrocolloid—directly shapes both taste release and powder behavior. The more control we have over addition, the more predictably the finished application matches the original R&D intent.
Long-term thinking matters in botanical extraction. Unchecked harvesting offshore threatens Picraena excelsa populations, and unscrupulous brokers may falsify origin claims. We commit to verified, documented sourcing. We participate in replanting programs—this is not a marketing story, but a requirement born of necessity. With every batch, we are aware that soil mineral content, water availability, and pest cycles ultimately shape the quality of what flows downstream.
Our sustainability also means attention to waste handling. Biomass left after extraction does not simply enter landfill or local burning. Instead, we compost or reintroduce it as natural fertilizer on partner fields. By comparing extraction residues’ macronutrient profile year-over-year, we monitor both soil impact and crop health—not as a green-washing exercise, but out of self-interest to preserve the supply for future cycles.
We've seen increased scrutiny from downstream companies who need transparency for their product chain. Whether they make beverages for European markets or plant-based pharmaceuticals for Asian suppliers, they want data to back sustainability and fair labor practice claims. Ten years ago, these conversations barely arose. Now, audits are routine, documentation must be airtight, and our partners join us in annual field reviews.
Years back, technical questions from new clients were routine: how best to dissolve the powder, which stabilizer to pair with, or how to prevent color pickup in a clear beverage. We have answered hundreds of experimental queries—using our own test kitchen results—sharing blending times, temperature windows, and even buffer recipes for beverage R&D. The close relationships we hold with buyers mean quicker troubleshooting. More than once, customers have sent in their failed powders, and our chemists have worked through reformulation, finding where the off-taste slipped in or which flow agent caused clumping.
Whether building a new extraction line or scaling from pilot to full shipment, we bring both lab and hands-on plant experience. Project managers frequently ask how we hone batch repeatability; our control charts, staff training logs, and vendor QC records all feed back into tight manufacturing and reliable customer outcomes.
In pesticide formulations, we support customers through regulatory hurdles too. This industry faces shifting approval profiles, especially in cross-border export. Documentation around natural origin, allowable usage thresholds, and lack of synthetic residues underpins market entry. Through tested limits on each shipment, we offer both technical and regulatory backing. Some clients have successfully registered spray products in new regions due to this level of technical and documentation detail, sidestepping the common stumbling blocks.
Demand for Picraena Excelsa does not stand still. New clinical studies, consumer trends, and regulatory frameworks keep the material in the spotlight. Our R&D keeps pace by investing in microfractionation, pilot-scale trials on new quassinoid analogs, and stability assessments for alternative dosage forms. Each quarter, we review literature for new medical or agricultural findings and translate those into production improvements. This is not blind mimicry of published trends, but a response to real feedback from researchers who approach us for custom needs.
We embrace automation and data gathering at every step—building digital logs into our processes to help us identify where a small drift can become a supply chain headache. Operators in our plant know that a seemingly trivial adjustment can extend stability, and do not hesitate to flag a deviation or question a reading. Our commitment in manufacturing means tight processes and a willingness to update with every proven new finding.
Collaborative projects have become a mainstay—whether developing in vitro assay support for pharmaceutical customers or trialing sprayable emulsions for commercial farming syndicates. By staying close to application scientists and field agronomists, we help tailor end-product results beyond generic product solutions.
Every kilo of Picraena Excelsa extract that moves from our production site carries the weight of years refining both technique and trust. We vouch for its stability, purity, and repeatability with every batch, based not on marketing intentions or abstract assurances, but on logged, traceable experience. By joining field experts, laboratory chemists, and processing engineers in one supply chain, we serve partners with the concrete data and technical input needed for high-value, finished goods. In an era when transparency and documented reliability draw a line between passing and failing, our manufacturing roots support every downstream product launch, formulation test, and regulatory submission.